Mustang Bio Inc. (NASDAQ: MBIO)
$0.40
+0.0041 ( +1.03% ) 1.2M
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Market Data
Open
$0.40
Previous close
$0.40
Volume
1.2M
Market cap
$13.06M
Day range
$0.39 - $0.41
52 week range
$0.13 - $5.66
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Apr 12, 2024 |
8-k | 8K-related | 13 | Mar 29, 2024 |
8-k | 8K-related | 14 | Mar 15, 2024 |
10-k | Annual reports | 81 | Mar 11, 2024 |
8-k | 8K-related | 16 | Mar 11, 2024 |
8-k | 8K-related | 14 | Feb 14, 2024 |
3 | Insider transactions | 1 | Feb 12, 2024 |
8-k | 8K-related | 12 | Jan 25, 2024 |
8-k | 8K-related | 12 | Jan 04, 2024 |
4 | Insider transactions | 1 | Jan 03, 2024 |